The natural small molecule folate, which has been extensively utilized for the selective delivery of diagnostic and therapeutic cargos to FOLR1+ cancer cells in vivo (39), represents an ideal chemical component to test the concept of chemically programmed biAbs side-by-side with a conventional biAb that uses an anti-human FOLR1 mAb. Here, FOLR1 is linked to cancer.